Session

PP 05 IBD (Posters)

THIOPURINES EXPOSURE IN-UTERO IS NOT ASSOCIATED WITH ABNORMAL HAEMATOLOGIC AND BIOCHEMICAL PARAMETERS IN INFANTS: A PICCOLO-X STUDY
THIOPURINES EXPOSURE IN-UTERO IS NOT ASSOCIATED WITH ABNORMAL HAEMATOLOGIC AND BIOCHEMICAL PARAMETERS IN INFANTS: A PICCOLO-X STUDY

TARGET ENGAGEMENT AND PHARMACODYNAMIC MOLECULAR MECHANISM EVALUATION IN A PHASE 1B STUDY OF THE NUCLEOTIDE-BINDING OLIGOMERIZATION DOMAIN, LEUCINE RICH REPEAT CONTAINING X1 (NLRX1) AGONIST NX-13 IN ULCERATIVE COLITIS
TARGET ENGAGEMENT AND PHARMACODYNAMIC MOLECULAR MECHANISM EVALUATION IN A PHASE 1B STUDY OF THE NUCLEOTIDE-BINDING OLIGOMERIZATION DOMAIN, LEUCINE RICH REPEAT CONTAINING X1 (NLRX1) AGONIST NX-13 IN ULCERATIVE COLITIS

COMBINING LEUCINE-RICH ALPHA-2 GLYCOPROTEIN AND FAECAL BIOMARKERS FOR ACCURATE MONITORING OF SMALL BOWEL ACTIVITY IN CROHN’S DISEASE
COMBINING LEUCINE-RICH ALPHA-2 GLYCOPROTEIN AND FAECAL BIOMARKERS FOR ACCURATE MONITORING OF SMALL BOWEL ACTIVITY IN CROHN’S DISEASE

HEALTH-RELATED QUALITY OF LIFE FROM THE INFLAMMATORY BOWEL DISEASE QUESTIONNAIRE AMONG PATIENTS WITH ULCERATIVE COLITIS STRATIFIED BY PRIOR AND CONCOMITANT THERAPIES: RESULTS FROM THE ETRASIMOD ELEVATE UC CLINICAL PROGRAMME
HEALTH-RELATED QUALITY OF LIFE FROM THE INFLAMMATORY BOWEL DISEASE QUESTIONNAIRE AMONG PATIENTS WITH ULCERATIVE COLITIS STRATIFIED BY PRIOR AND CONCOMITANT THERAPIES: RESULTS FROM THE ETRASIMOD ELEVATE UC CLINICAL PROGRAMME

A SINGLE CENTRE AUDIT REVIEWING THE PRACTICE OF ACUTE SEVERE ULCERATIVE COLITIS (ASUC) MANAGEMENT USING CALCINEURIN INHIBITOR AND BIOLOGICAL THERAPY. ARE THEY SHOWING GOOD OUTCOME AND SUCCESS IN AVOIDING COLECTOMY AT 30 DAYS AND 1 YEAR MARK?
A SINGLE CENTRE AUDIT REVIEWING THE PRACTICE OF ACUTE SEVERE ULCERATIVE COLITIS (ASUC) MANAGEMENT USING CALCINEURIN INHIBITOR AND BIOLOGICAL THERAPY. ARE THEY SHOWING GOOD OUTCOME AND SUCCESS IN AVOIDING COLECTOMY AT 30 DAYS AND 1 YEAR MARK?

PREDICTORS OF ILLNESS TRAJECTORY IN NEWLY DIAGNOSED ULCERATIVE COLITIS: A 3-YEAR FOLLOW-UP COHORT STUDY
PREDICTORS OF ILLNESS TRAJECTORY IN NEWLY DIAGNOSED ULCERATIVE COLITIS: A 3-YEAR FOLLOW-UP COHORT STUDY

IMPACT OF ETRASIMOD ON BLOOD PRESSURE AND HYPERTENSION: DATA FROM THE ETRASIMOD ULCERATIVE COLITIS CLINICAL PROGRAMME
IMPACT OF ETRASIMOD ON BLOOD PRESSURE AND HYPERTENSION: DATA FROM THE ETRASIMOD ULCERATIVE COLITIS CLINICAL PROGRAMME

ENDOCANNABINOID SYSTEM IN INFLAMMATORY BOWEL DISEASES: MUCOSAL GENE EXPRESSION PRELIMINARY DATA
ENDOCANNABINOID SYSTEM IN INFLAMMATORY BOWEL DISEASES: MUCOSAL GENE EXPRESSION PRELIMINARY DATA

CIRCULATING MIRNAS IN INFLAMMATORY BOWEL DISEASES - PRELIMINARY RESULTS
CIRCULATING MIRNAS IN INFLAMMATORY BOWEL DISEASES - PRELIMINARY RESULTS

THE IMPACT OF COVID-19 ON THE THERAPEUTIC DECISIONS AND MONITORING OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A RETROSPECTIVE SINGLE-CENTER STUDY
THE IMPACT OF COVID-19 ON THE THERAPEUTIC DECISIONS AND MONITORING OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A RETROSPECTIVE SINGLE-CENTER STUDY

MICROSCOPIC COLITIS AND RISK OF INCIDENT ACUTE PANCREATITIS: A NATIONWIDE POPULATION-BASED MATCHED COHORT STUDY
MICROSCOPIC COLITIS AND RISK OF INCIDENT ACUTE PANCREATITIS: A NATIONWIDE POPULATION-BASED MATCHED COHORT STUDY

PREDICTORS OF RELAPSE IN CASES OF ULCERATIVE COLITIS THAT ACHIEVED MUCOSAL HEALING WITH BIOLOGICS
PREDICTORS OF RELAPSE IN CASES OF ULCERATIVE COLITIS THAT ACHIEVED MUCOSAL HEALING WITH BIOLOGICS

ALISTIPES PUTREDINIS IS A KEY SPECIES OF FECAL MICROBIOTA TRANSPLANTATION FOR ULCERATIVE COLITIS
ALISTIPES PUTREDINIS IS A KEY SPECIES OF FECAL MICROBIOTA TRANSPLANTATION FOR ULCERATIVE COLITIS

INCREASED RISK OF CIRRHOSIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A DANISH REGISTRY-BASED COHORT STUDY (1998-2018)
INCREASED RISK OF CIRRHOSIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A DANISH REGISTRY-BASED COHORT STUDY (1998-2018)

IRON-DEFICIENCY REFRACTORY ANEMIA (IDRA) IN SARDINIAN INFLAMMATORY BOWEL DISEASE PATIENTS: A LONGITUDINAL OBSERVATIONAL STUDY
IRON-DEFICIENCY REFRACTORY ANEMIA (IDRA) IN SARDINIAN INFLAMMATORY BOWEL DISEASE PATIENTS: A LONGITUDINAL OBSERVATIONAL STUDY

EFFECTIVENESS OF PARTIAL ENTERAL NUTRITION TO TREAT ADULTS WITH CROHN’S DISEASE WHO LOST RESPONSE TO BIOLOGICAL THERAPY
EFFECTIVENESS OF PARTIAL ENTERAL NUTRITION TO TREAT ADULTS WITH CROHN’S DISEASE WHO LOST RESPONSE TO BIOLOGICAL THERAPY

OUTCOMES OF VEDOLIZUMAB DOSE INTENSIFICATION: RESULTS FROM AN ASIAN INFLAMMATORY BOWEL DISEASE (IBD) COHORT STUDY
OUTCOMES OF VEDOLIZUMAB DOSE INTENSIFICATION: RESULTS FROM AN ASIAN INFLAMMATORY BOWEL DISEASE (IBD) COHORT STUDY

PREVALENCE AND MANAGEMENT OF DASATINIB-INDUCED GASTROINTESTINAL DISORDERS: A STUDY AT OUR HOSPITAL
PREVALENCE AND MANAGEMENT OF DASATINIB-INDUCED GASTROINTESTINAL DISORDERS: A STUDY AT OUR HOSPITAL

ANALYSIS OF HISTOLOGICAL FEATURES PREDICTING THE RESPONSE TO VEDOLIZUMAB IN PATIENTS WITH ULCERATIVE COLITIS
ANALYSIS OF HISTOLOGICAL FEATURES PREDICTING THE RESPONSE TO VEDOLIZUMAB IN PATIENTS WITH ULCERATIVE COLITIS

DEVELOPMENT AND VALIDATION OF A MULTIFUNCTIONAL FREE ACCESS TELEMEDICINE MOBILE APP FOCUSED ON SPANISH-SPEAKING PATIENTS WITH INFLAMMATORY BOWEL DISEASE
DEVELOPMENT AND VALIDATION OF A MULTIFUNCTIONAL FREE ACCESS TELEMEDICINE MOBILE APP FOCUSED ON SPANISH-SPEAKING PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Item 741 - 760 / 826
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37
38
39 40 41 42